Targacept, Inc. to Present at 2010 Deutsche Bank BioFEST
WINSTON-SALEM, N.C.--(BUSINESS WIRE)--Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR Therapeutics™, today announced that J. Donald deBethizy, Ph.D., President and Chief Executive Officer, is scheduled to present at the 2010 Deutsche Bank BioFEST at the Four Seasons Hotel in Boston, Massachusetts on Tuesday, December 14, 2010 at 1:35 p.m. Eastern Time.